Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Claritas Pharmaceuticals Inc
BCSC-OSC Revocation of Cease Trade Order
Business
Jan 22 2021
3 min read

BCSC-OSC Revocation of Cease Trade Order


Citation: 2021 BCSECCOM 26

Revocation Order

Kalytera Therapeutics, Inc.

Under the securities legislation of British Columbia and Ontario
(the Legislation)

Background

¶ 1 Kalytera Therapeutics, Inc. (the Issuer) is subject to a failure-to-file cease trade order (the FFCTO) issued by the regulator of the British Columbia Securities Commission (the Principal Regulator) and Ontario (each a Decision Maker) respectively on June 22, 2020.

¶ 2 The Issuer has applied to each of the Decision Makers under National Policy 11-207 Failure-to-File Cease Trade Orders and Revocation in Multiple Jurisdictions (NP 11-207) for an order revoking the FFCTOs.

¶ 3 This order is the order of the Principal Regulator and evidences the decision of the Decision Maker in Ontario.

Interpretation

¶ 4 Terms defined in National Instrument 14-101 Definitions or in NP 11-207 have the same meaning if used in this order, unless otherwise defined.

Order

¶ 5 Each of the Decision Makers is satisfied that the order to revoke the FFCTO meets the test set out in the Legislation for the Decision Maker to make the decision.

¶ 6 The decision of the Decision Makers under the Legislation is that the FFCTO is revoked.

¶ 7 January 22, 2021

Allan Lim, CPA, CA
Manager
Corporate Finance

Original